regorafenib (Rx)

Dosage Forms & Strengths

tablet

• 40mg

Colorectal Cancer

Indicated for the treatment of patients with metastatic colorectal cancer (CRC) who have been previously treated with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy, an anti-VEGF therapy, and, if RAS wild type, an anti-EGFR therapy

160 mg (four 40-mg tablets) PO qDay for the first 21 days of each 28-day cycle

Continue treatment until disease progression or unacceptable toxicity

Also see Administration

Gastrointestinal Stromal Tumors

Indicated for the treatment of locally advanced, unresectable or metastatic gastrointestinal stromal tumor (GIST) in patients who have been previously treated with imatinib mesylate and sunitinib

160 mg (four 40-mg tablets) PO qDay for the first 21 days of each 28-day cycle

Continue treatment until disease progression or unacceptable toxicity

Also see Administration

https://reference.medscape.com/drug/stivarga-regorafenib-999774

……see more….

———————

💮[MaruLabX – Science-based wellness support for everyday health. 🇺🇸]

——————-

MaruLabX Co.Ltd

Website: MaruLabx.com

#MaruLabX #HealthTips #HealthyLiving #Wellness #HealthAwareness #SelfCare #LiveWell #HolisticHealth #DailyHealth #HealthyLifestyle #HealthGoals